Clinical Trial Update: A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating LY01015 plus chemotherapy versus Opdivo plus chemotherapy in advanced or metastatic esophageal squamous cell carcinoma and is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• LY01015
• OPDIVO (nivolumab)

Snippet

Sponsor: Shandong Boan Biotechnology Co., Ltd | Conditions: Esophageal Squamous Cell Carcinoma | Phase 3 | Status: RECRUITING